日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Exosomal long noncoding RNA MLETA1 promotes tumor progression and metastasis by regulating the miR-186-5p/EGFR and miR-497-5p/IGF1R axes in non-small cell lung cancer

外泌体长链非编码 RNA MLETA1 通过调节非小细胞肺癌中的 miR-186-5p/EGFR 和 miR-497-5p/IGF1R 轴促进肿瘤进展和转移

Xiu-Rui Hsu, Jia-En Wu, Yi-Ying Wu, Sheng-Yen Hsiao, Jui-Lin Liang, Ya-Ju Wu, Chia-Hao Tung, Meng-Fan Huang, Ming-Shiu Lin, Pan-Chyr Yang, Yuh-Ling Chen, Tse-Ming Hong

TRPC7 facilitates cell growth and migration by regulating intracellular Ca2+ mobilization in lung adenocarcinoma cells

TRPC7 通过调节肺腺癌细胞内的 Ca2+ 动员促进细胞生长和迁移

Jui-Lin Liang, Ming-Hsien Tsai, Yi-Chun Hsieh, Huei-Syuan Liu, Shao-Wei Chen, Yung-Yun Huang, Li-Ching Lin, Tsung-Fu Tsai, Yun-Fang Liang, Wen-Li Hsu0

Nociceptive transient receptor potential canonical 7 (TRPC7) mediates aging-associated tumorigenesis induced by ultraviolet B

伤害性瞬时受体电位典型 7 (TRPC7) 介导紫外线 B 诱发的衰老相关肿瘤发生

Wen-Li Hsu, Ming-Hsien Tsai, Ching-Ying Wu, Jui-Lin Liang, Jian-He Lu, Jennifer S Kahle, Hsin-Su Yu, Chia-Jung Yen, Chen-Tung Yen, Yi-Chun Hsieh, Yung-Yun Huang, Li-Ching Lin, Tsung-Fu Tsai, Chu-Huang Chen, Tohru Yoshioka

miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer

miR-105/93-3p 促进化疗耐药,循环 miR-105/93-3p 可作为三阴性乳腺癌的诊断生物标志物

Hao-Yi Li, Jui-Lin Liang, Yao-Lung Kuo, Hao-Hsien Lee, Marcus J Calkins, Hong-Tai Chang, Forn-Chia Lin, Yu-Chia Chen, Tai-I Hsu, Michael Hsiao, Luo-Ping Ger, Pei-Jung Lu

Hydrogen gas protects IP3Rs by reducing disulfide bridges in human keratinocytes under oxidative stress

氢气通过还原氧化应激下人类角质形成细胞中的二硫键来保护 IP3R

Ching-Ying Wu, Wen-Li Hsu, Ming-Hsien Tsai, Jui-Lin Liang, Jian-He Lu, Chia-Jung Yen, Hsin-Su Yu, Mami Noda, Chi-Yu Lu, Chu-Huang Chen, Shian-Jang Yan, Tohru Yoshioka6